Cortexyme, Inc. (CRTX) Social Stream



Cortexyme, Inc. (CRTX): $1.95

0.05 (+2.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Cortexyme Inc (CRTX) Price Targets From Analysts

Use the tables below to see what analysts covering Cortexyme Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $150 $17 $54.25 $6.19 776.41%
2022-01-10 3 $150 $17 $65.666 $6.19 960.84%
2022-01-26 4 $150 $6 $62 $6.19 901.62%
2022-03-02 4 $30 $6 $16 $6.19 158.48%
2022-03-03 4 $30 $5 $15.666 $6.19 153.09%
2022-03-22 4 $15 $5 $10.666 $6.19 72.31%

The Trend in the Analyst Price Target


Over the past 14 months, CRTX's average price target has gone down $65.08.

Over the past 50 weeks, CRTX's average upside potential has been 150.51%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-22 8 190 14 71.290 37.47 90.26%
2021-07-03 8 190 14 73.860 55.15 33.93%
2021-07-10 8 190 14 73.860 57.45 28.56%
2021-09-19 8 221 14 108.430 87.79 23.51%
2022-03-03 4 30 5 15.666 4.30 264.33%

CRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.75 1 0 2 0 0 4

The Trend in the Broker Recommendations


CRTX's average broker recommendation rating improved by 0.11 over the prior 151 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRTX as an investment opportunity.

  • CRTX has a lower variance in analysts' estimates than -584.06% of all US stocks.
  • In terms of how Cortexyme Inc fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 644.45% of that group.
  • Cortexyme Inc's number of analysts covering the stock is higher than 95.9% of stocks in the mid market cap category.
  • In the context of stocks in the mid market cap category, Cortexyme Inc's average analyst price target is greater than 309.33% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Cortexyme Inc are CCCC, BEAM, and BCRX.

Is CRTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4342 seconds.